News

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a ...
Shares of Charles River Laboratories International Inc. CRL rose 1.73% to $106.05 Thursday, on what proved to be an ...
Charles River (CRL) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...
Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2025 financial results on Wednesday, May 7th, before the market opens. A conference call has been scheduled to ...
Baird analyst Eric Coldwell raised the firm’s price target on Charles River (CRL) to $118 from $101 and keeps a Neutral rating on the shares.
In trading on Tuesday, shares of Charles River Laboratories International Inc. (Symbol: CRL) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low as $105.18 ...
Detailed price information for Charles River Laboratories Intl (CRL-N) from The Globe and Mail including charting and trades.
Oncodesign Services has announced the appointment of Aidan Synnott as its new Chief Executive Officer (CEO). Synnott has more ...
Charles River Laboratories CRL shares rallied 6.9% in the last trading session to close at $106.60. This move can be attributable to notable volume with a higher number of shares being traded than ...